In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness FDA Peptide Reclassification 2026: What It Means for Providers